Company Begins Telemedicine Program With U.K. University

SUN VALLEY, CA–(EMWNews – July 22, 2008) – XTend Medical Corporation (PINKSHEETS: XMDC), a company that delivers cutting-edge telemedicine solutions to the

healthcare industry, announced today the company will begin a telemedicine

program in Europe to track the remote monitoring of diabetic patients in

early August. According to Frost and Sullivan the European market is

expected to hit $236 Million by 2014.

The company released the following statement: “Our presence here in the

U.S. has attracted many companies from Europe that are interested on our

telehealth programs. While many companies offer a similar solution, the

fact that XTend’s solution was chosen over these is critical in the fact

that our solutions are widely accepted as being the easiest to implement

and maintain. This is a major accomplishment as our marketing efforts in

educating the medical community as to the ease with which our system can be

integrated into their practice has proven once again to stand above our

competitor’s solutions. By having a presence in Europe, this will assist

the company as we grow our brand globally over the next three years and on.

We’ll release further information regarding our European program as the

results are monitored through the University that has asked us to maintain

their privacy for now,” stated Mr. Paul D. Lisenby, CEO of XTend Medical.

For any healthcare agency or physician group that would like to find out

more about how XTend can assist in your management of diabetic patients,

please visit the company website at www.xtendmedical.com or email us at

info@xtendmedical.com

About XTend Medical: XTend Medical Corporation markets and sells telehealth

and telemedicine solutions for monitoring and caring for patients with

chronic disease conditions. XTend has developed a complete Remote Diabetic

Patient Monitoring System that is currently being used by physicians and

other healthcare agencies throughout the U.S. Through their alliances,

XTend offers pharmacy services, diabetic supplies, and telemedicine

products that increase patient care yet reduce costs associated with

servicing those patients. For more information, please visit their website

at www.xtendmedical.com.

Safe Harbor

This press release contains or may contain forward-looking statements such

as statements regarding the Company’s growth and profitability, growth

strategy, liquidity and access to public markets, operating expense

reduction, and trends in the industry in which the Company operates. The

forward-looking statements contained in this press release are also subject

to other risks and uncertainties, including those more fully described in

the Company’s filings with the Securities and Exchange Commission. The

Company assumes no obligation to update these forward-looking statements to

reflect actual results, changes in risks, uncertainties or assumptions

underlying or affecting such statements, or for prospective events that may

have a retroactive effect.